Judges

A South Australian wind farm developer has lost its appeal of ruling ordering it to make a $21 million progress payment to joint venture partners GE Renewable Energy and Elecnor.

The owner of the Callide power station in Queensland, IG Power, has won court approval for a recapitalisation that will see major shareholder Sev.en inject millions to cover its debts.

Keybridge CEO Nick Bolton has won a stay of orders ending the company's administration as he appeals that ruling and another that found he and two other directors were validly removed and replaced at a board meeting.

Ben Roberts-Smith has accused Nine journalist Nick McKenzie of using his lawyers as a "shield" against claims he had access to confidential and privileged legal strategy in the former soldier's failed defamation case.

The owner of the Seasons of Perth Hotel seeks want to quash a review determination of an adjudicator's decision in its dispute with hotel construction company Reward Group over performance bonds for work on the hotel.

The High Court has been asked to weigh in on when a court should step in when the machinery governing the entitlement to payments in a contract breaks down, in a dispute between luxury home builder Glenvill and Amcor over asbestos remediation at an industrial site in the Melbourne suburb of Alphington.

While granting yet another extension, a judge has read the riot act to Airservices Australia for its breaches of court orders to file evidence in Brisbane Airport's $690 million case over PFAS chemical use.

Court approval of a $50 million settlement in a class action against ANZ and superannuation trustee OnePath has been delayed, after 22,000 group members were excluded from an opt-out notice due to a problem with OnePath's computing process.

The Full Court has granted a cross-appeal by crypto currency provider Block Earner, finding its did not need a financial services licence because its crypto product is not a financial product.

Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.